PT2252263E - Forma galénica para a administração de triptanos por via transmucosa bucal - Google Patents

Forma galénica para a administração de triptanos por via transmucosa bucal Download PDF

Info

Publication number
PT2252263E
PT2252263E PT09706112T PT09706112T PT2252263E PT 2252263 E PT2252263 E PT 2252263E PT 09706112 T PT09706112 T PT 09706112T PT 09706112 T PT09706112 T PT 09706112T PT 2252263 E PT2252263 E PT 2252263E
Authority
PT
Portugal
Prior art keywords
active ingredient
triptans
transmucosal delivery
oral transmucosal
galenic form
Prior art date
Application number
PT09706112T
Other languages
English (en)
Inventor
Philippe Perovitch
Marc Maury
Original Assignee
Philippe Perovitch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philippe Perovitch filed Critical Philippe Perovitch
Publication of PT2252263E publication Critical patent/PT2252263E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT09706112T 2008-01-30 2009-01-29 Forma galénica para a administração de triptanos por via transmucosa bucal PT2252263E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0850571A FR2926721B1 (fr) 2008-01-30 2008-01-30 Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans

Publications (1)

Publication Number Publication Date
PT2252263E true PT2252263E (pt) 2011-10-19

Family

ID=39766922

Family Applications (1)

Application Number Title Priority Date Filing Date
PT09706112T PT2252263E (pt) 2008-01-30 2009-01-29 Forma galénica para a administração de triptanos por via transmucosa bucal

Country Status (15)

Country Link
US (1) US9801815B2 (pt)
EP (1) EP2252263B1 (pt)
JP (1) JP5435659B2 (pt)
CN (1) CN101983052B (pt)
AT (1) ATE516015T1 (pt)
BR (1) BRPI0907203A2 (pt)
CA (1) CA2713163C (pt)
DK (1) DK2252263T3 (pt)
ES (1) ES2369747T3 (pt)
FR (1) FR2926721B1 (pt)
MX (1) MX2010008285A (pt)
PL (1) PL2252263T3 (pt)
PT (1) PT2252263E (pt)
RU (1) RU2492852C2 (pt)
WO (1) WO2009095621A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3031668A1 (fr) 2015-01-20 2016-07-22 Philippe Perovitch Dispositif d'administration d'un principe actif par voie per-muqueuse buccale.
FR3053244A1 (fr) 2016-07-01 2018-01-05 Philippe Perovitch Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
JP3350061B2 (ja) * 1997-07-03 2002-11-25 ファイザー・インク エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Also Published As

Publication number Publication date
CA2713163A1 (fr) 2009-08-06
EP2252263A1 (fr) 2010-11-24
JP5435659B2 (ja) 2014-03-05
US20100298401A1 (en) 2010-11-25
WO2009095621A1 (fr) 2009-08-06
DK2252263T3 (da) 2011-10-31
BRPI0907203A2 (pt) 2015-07-14
EP2252263B1 (fr) 2011-07-13
CA2713163C (fr) 2016-11-08
FR2926721B1 (fr) 2011-07-22
CN101983052A (zh) 2011-03-02
US9801815B2 (en) 2017-10-31
RU2010136277A (ru) 2012-03-10
ATE516015T1 (de) 2011-07-15
ES2369747T3 (es) 2011-12-05
JP2011510962A (ja) 2011-04-07
RU2492852C2 (ru) 2013-09-20
PL2252263T3 (pl) 2011-12-30
MX2010008285A (es) 2010-10-04
CN101983052B (zh) 2013-03-20
FR2926721A1 (fr) 2009-07-31

Similar Documents

Publication Publication Date Title
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
WO2008027854A3 (en) Pharmaceutical compositions comprising hgh for oral delivery
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
CL2011000642A1 (es) Unidad de dosificacion que comprende 25 a 400 mg del acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico; kit farmaceutico que comprende la unidad de dosificacion; y su uso para el tratamiento de fibrosis quistica.
TN2010000152A1 (en) Pharmaceutical compositions
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
NZ595467A (en) Sublingual pharmaceutical composition comprising a neutral oil
MX2010008235A (es) Nueva dosificacion y formulacion.
MX339470B (es) Formulacion que contiene nicotina.
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
WO2008087323A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
PT2252263E (pt) Forma galénica para a administração de triptanos por via transmucosa bucal
WO2008051527A3 (en) Sustained release of agents for localized pain management
MX2011006797A (es) Una formulación para administración oral transmucósica de fármacos reductores de lípidos.
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
MA32722B1 (fr) Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion
WO2011063775A3 (en) Pectin complexes of sartans and pharmaceutical compositions based thereon
MY148266A (en) Galenical formulations of aliskiren
WO2008065144A3 (en) Galenic formulations of organic compounds
TN2011000107A1 (en) Galenical formulation comprising aliskiren and process for its preparation by melt extrusion granulation
TNSN06335A1 (en) Novel stable oral risperidone solution